Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Centre Oscar Lambret
University of Florida
Children's Oncology Group
M.D. Anderson Cancer Center
Columbia University
Medical College of Wisconsin
Seattle Children's Hospital
Seattle Children's Hospital
University of Florida
Baylor College of Medicine
Emory University
Actuate Therapeutics Inc.
Columbia University
Beijing Tiantan Hospital
M.D. Anderson Cancer Center
Chulalongkorn University
Nationwide Children's Hospital
Jazz Pharmaceuticals
Bambino Gesù Hospital and Research Institute
Bexion Pharmaceuticals, Inc.
Capital Medical University
Capital Medical University
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Columbia University
Emory University
University of California, San Francisco
St. Jude Children's Research Hospital
Children's Hospital Medical Center, Cincinnati
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium
Shenzhen Geno-Immune Medical Institute
Lumos Pharma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Jude Children's Research Hospital
Fundació Sant Joan de Déu
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital